Evaluation of Glycemia Control Achieved by Glargine and Lispro Versus Detemir and Aspart Insulin Regimes in Type 2 Diabetics Undergoing Surgery

Mushtaq Ahmad 1, *, Z.A Wafai2, S.K Mathur3, S Lodha4, Z.Y Khan3, Alka Bansal 3
1 Department of Pharmacology, Punjab Institute of Medical Sciences, Jalandhar
2 Department of Clinical Pharmacology, Sheri-I- Kashmir Institute of Medical Sciences, Srinagar
3 Department of Endocrinology, S. M. S. Medical College & Hospital, Jaipur
4 Department of Endocrinology, Fortis Escorts Hospital, Jaipur

Article Metrics

CrossRef Citations:
Total Statistics:

Full-Text HTML Views: 1671
Abstract HTML Views: 697
PDF Downloads: 346
Total Views/Downloads: 2714
Unique Statistics:

Full-Text HTML Views: 904
Abstract HTML Views: 376
PDF Downloads: 246
Total Views/Downloads: 1526

Creative Commons License
© Ahmad et al.; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the Punjab Institute of Medical Sciences, Punjab, India; Tel: +91-8699013755; E-mail:


There is paucity of scientific literature regarding the clinical outcome of long lasting basal insulin and rapid acting mealtime insulin regimes in surgical situations although employed in non-surgical situations. This study has evaluated the clinical outcome of two subcutaneous split-mixed Glargine+Lispro and Detemir+Aspart insulin regimes in type 2 diabetics undergoing surgery.

Keywords: Aspart, Detemir, Glargine, Lispro, Surgery, Type 2 DM patients.